Dermatologist recommended topical Dutasteride 15% once a week – anyone tried this?
    Finasteride/Dutasteride 10/17/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💧 Dutasteride (topical) 15% 1x weekly
    💊 Finasteride (oral)
    💧 Minoxidil (topical) 2x daily
    the tone is 😐 neutral.

    Other terms

    A dermatologist recommended using topical Dutasteride (15%) once a week, alongside oral Finasteride and Minoxidil, to improve hair strength and response. The user is seeking experiences or evidence on the effectiveness of this high-concentration regimen.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.

      research Platelet-rich plasma in androgenetic alopecia

      1 citations , January 2021 in “Indian Dermatology Online Journal”
      This expert group provided recommendations for preparing and using platelet-rich plasma in treating androgenetic alopecia, suggesting a manual double-spin method and specific dosing, although further studies on injectable platelet-rich fibrin are needed.

      research Novel agents for the treatment of alopecia

      29 citations , December 1998 in “Seminars in Cutaneous Medicine and Surgery”
      This review examines recent approvals and emerging treatments for androgenetic alopecia, discussing newly approved drugs like Propecia and Rogaine Extra Strength 5%, but without presenting new clinical results.

      research Hormonal contraceptives: pharmacology tailored to women's health

      88 citations , June 2016 in “Human Reproduction Update”
      This review discusses developments in oral contraceptives, highlighting improved individualization, reduced side effects, and enhanced suitability for various women's health needs, but it reports no new clinical results.

      research An overview of female pattern hair loss

      2 citations , June 2011 in “Expert Review of Dermatology”
      This review discusses the characteristics and management options for female pattern hair loss, highlighting the unclear role of androgens and the psychosocial impact, and reports no new clinical results.